<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2025, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 13 Nov 2024 09:34:00 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>HealthWarehouse.com Reports Results for Third Quarter 2024</title>
   <link>http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Third+Quarter+2024/23971470.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Company Hits Record High Revenues and Cash Flow; Extends Convertible Note Maturity Date to 2026

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and nine months ended September 30, 2024. The Company reported net sales for the third quarter of $9.0 million, an 89% increase over the same period in 2023, resulting from strong growth in prescription sales revenue. The Company reported net income of $74,000 and Adjusted EBITDA, a non-GAAP measure defined below, of $405,000 for the quarter.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on healthcare e-commerce, sells and delivers</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Third+Quarter+2024/23971470.html</guid>
   <pubDate>Wed, 13 Nov 2024 09:34:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for Third Quarter 2024</title>
   <link>http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Third+Quarter+2024/23971470.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Company Hits Record High Revenues and Cash Flow; Extends Convertible Note Maturity Date to 2026

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and nine months ended September 30, 2024. The Company reported net sales for the third quarter of $9.0 million, an 89% increase over the same period in 2023, resulting from strong growth in prescription sales revenue. The Company reported net income of $74,000 and Adjusted EBITDA, a non-GAAP measure defined below, of $405,000 for the quarter.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on healthcare e-commerce, sells and delivers</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Third+Quarter+2024/23971470.html</guid>
   <pubDate>Wed, 13 Nov 2024 09:34:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for Third Quarter 2024</title>
   <link>http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Third+Quarter+2024/23971470.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Company Hits Record High Revenues and Cash Flow; Extends Convertible Note Maturity Date to 2026

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and nine months ended September 30, 2024. The Company reported net sales for the third quarter of $9.0 million, an 89% increase over the same period in 2023, resulting from strong growth in prescription sales revenue. The Company reported net income of $74,000 and Adjusted EBITDA, a non-GAAP measure defined below, of $405,000 for the quarter.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on healthcare e-commerce, sells and delivers</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Third+Quarter+2024/23971470.html</guid>
   <pubDate>Wed, 13 Nov 2024 09:34:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for Third Quarter 2024</title>
   <link>http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Third+Quarter+2024/23971470.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Company Hits Record High Revenues and Cash Flow; Extends Convertible Note Maturity Date to 2026

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and nine months ended September 30, 2024. The Company reported net sales for the third quarter of $9.0 million, an 89% increase over the same period in 2023, resulting from strong growth in prescription sales revenue. The Company reported net income of $74,000 and Adjusted EBITDA, a non-GAAP measure defined below, of $405,000 for the quarter.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on healthcare e-commerce, sells and delivers</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Third+Quarter+2024/23971470.html</guid>
   <pubDate>Wed, 13 Nov 2024 09:34:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for Third Quarter 2024</title>
   <link>http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Third+Quarter+2024/23971470.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Company Hits Record High Revenues and Cash Flow; Extends Convertible Note Maturity Date to 2026

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and nine months ended September 30, 2024. The Company reported net sales for the third quarter of $9.0 million, an 89% increase over the same period in 2023, resulting from strong growth in prescription sales revenue. The Company reported net income of $74,000 and Adjusted EBITDA, a non-GAAP measure defined below, of $405,000 for the quarter.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on healthcare e-commerce, sells and delivers</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Third+Quarter+2024/23971470.html</guid>
   <pubDate>Wed, 13 Nov 2024 09:34:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for Third Quarter 2024</title>
   <link>http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Third+Quarter+2024/23971470.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Company Hits Record High Revenues and Cash Flow; Extends Convertible Note Maturity Date to 2026

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and nine months ended September 30, 2024. The Company reported net sales for the third quarter of $9.0 million, an 89% increase over the same period in 2023, resulting from strong growth in prescription sales revenue. The Company reported net income of $74,000 and Adjusted EBITDA, a non-GAAP measure defined below, of $405,000 for the quarter.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on healthcare e-commerce, sells and delivers</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Third+Quarter+2024/23971470.html</guid>
   <pubDate>Wed, 13 Nov 2024 09:34:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for Third Quarter 2024</title>
   <link>http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Third+Quarter+2024/23971470.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Company Hits Record High Revenues and Cash Flow; Extends Convertible Note Maturity Date to 2026

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and nine months ended September 30, 2024. The Company reported net sales for the third quarter of $9.0 million, an 89% increase over the same period in 2023, resulting from strong growth in prescription sales revenue. The Company reported net income of $74,000 and Adjusted EBITDA, a non-GAAP measure defined below, of $405,000 for the quarter.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on healthcare e-commerce, sells and delivers</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Third+Quarter+2024/23971470.html</guid>
   <pubDate>Wed, 13 Nov 2024 09:34:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for Third Quarter 2024</title>
   <link>http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Third+Quarter+2024/23971470.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Company Hits Record High Revenues and Cash Flow; Extends Convertible Note Maturity Date to 2026

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and nine months ended September 30, 2024. The Company reported net sales for the third quarter of $9.0 million, an 89% increase over the same period in 2023, resulting from strong growth in prescription sales revenue. The Company reported net income of $74,000 and Adjusted EBITDA, a non-GAAP measure defined below, of $405,000 for the quarter.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on healthcare e-commerce, sells and delivers</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Third+Quarter+2024/23971470.html</guid>
   <pubDate>Wed, 13 Nov 2024 09:34:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com, Inc. (HEWA) Reports Q2 Loss of $0.01</title>
   <link>http://www.streetinsider.com/Earnings/HealthWarehouse.com%2C+Inc.+%28HEWA%29+Reports+Q2+Loss+of+%240.01/23590827.html</link>
   <description>&lt;p&gt;HealthWarehouse.com, Inc. (OTC: HEWA) reported Q2 EPS of ($0.01). Revenue for the quarter came in at $5.8 million.&lt;/p&gt;&lt;p&gt;For earnings history and earnings-related data on HealthWarehouse.com, Inc. (HEWA) &lt;a href=&quot;http://www.streetinsider.com/ec_earnings.php?q=HEWA&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Earnings/HealthWarehouse.com%2C+Inc.+%28HEWA%29+Reports+Q2+Loss+of+%240.01/23590827.html</guid>
   <pubDate>Tue, 13 Aug 2024 10:15:29 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for Second Quarter 2024</title>
   <link>http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2024/23587305.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Reports 9% Increase in Revenues; GLP-1 Medications Contribute to Growth

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and six months ended June 30, 2024. The Company reported net sales for the second quarter of 2024 of $5.8 million, a 9% increase over the same period in 2023, resulting from strong growth in partner services and B2C prescription revenue. The Company reported a net loss of $344,000 for the quarter and a net loss of $596,000 for the six months ended June 30, 2024.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2024/23587305.html</guid>
   <pubDate>Mon, 12 Aug 2024 17:16:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for Second Quarter 2024</title>
   <link>http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2024/23587305.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Reports 9% Increase in Revenues; GLP-1 Medications Contribute to Growth

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and six months ended June 30, 2024. The Company reported net sales for the second quarter of 2024 of $5.8 million, a 9% increase over the same period in 2023, resulting from strong growth in partner services and B2C prescription revenue. The Company reported a net loss of $344,000 for the quarter and a net loss of $596,000 for the six months ended June 30, 2024.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2024/23587305.html</guid>
   <pubDate>Mon, 12 Aug 2024 17:16:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for Second Quarter 2024</title>
   <link>http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2024/23587305.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Reports 9% Increase in Revenues; GLP-1 Medications Contribute to Growth

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and six months ended June 30, 2024. The Company reported net sales for the second quarter of 2024 of $5.8 million, a 9% increase over the same period in 2023, resulting from strong growth in partner services and B2C prescription revenue. The Company reported a net loss of $344,000 for the quarter and a net loss of $596,000 for the six months ended June 30, 2024.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2024/23587305.html</guid>
   <pubDate>Mon, 12 Aug 2024 17:16:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for Second Quarter 2024</title>
   <link>http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2024/23587305.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Reports 9% Increase in Revenues; GLP-1 Medications Contribute to Growth

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and six months ended June 30, 2024. The Company reported net sales for the second quarter of 2024 of $5.8 million, a 9% increase over the same period in 2023, resulting from strong growth in partner services and B2C prescription revenue. The Company reported a net loss of $344,000 for the quarter and a net loss of $596,000 for the six months ended June 30, 2024.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2024/23587305.html</guid>
   <pubDate>Mon, 12 Aug 2024 17:16:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for Second Quarter 2024</title>
   <link>http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2024/23587305.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Reports 9% Increase in Revenues; GLP-1 Medications Contribute to Growth

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and six months ended June 30, 2024. The Company reported net sales for the second quarter of 2024 of $5.8 million, a 9% increase over the same period in 2023, resulting from strong growth in partner services and B2C prescription revenue. The Company reported a net loss of $344,000 for the quarter and a net loss of $596,000 for the six months ended June 30, 2024.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2024/23587305.html</guid>
   <pubDate>Mon, 12 Aug 2024 17:16:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for Second Quarter 2024</title>
   <link>http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2024/23587305.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Reports 9% Increase in Revenues; GLP-1 Medications Contribute to Growth

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and six months ended June 30, 2024. The Company reported net sales for the second quarter of 2024 of $5.8 million, a 9% increase over the same period in 2023, resulting from strong growth in partner services and B2C prescription revenue. The Company reported a net loss of $344,000 for the quarter and a net loss of $596,000 for the six months ended June 30, 2024.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2024/23587305.html</guid>
   <pubDate>Mon, 12 Aug 2024 17:16:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for Second Quarter 2024</title>
   <link>http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2024/23587305.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Reports 9% Increase in Revenues; GLP-1 Medications Contribute to Growth

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and six months ended June 30, 2024. The Company reported net sales for the second quarter of 2024 of $5.8 million, a 9% increase over the same period in 2023, resulting from strong growth in partner services and B2C prescription revenue. The Company reported a net loss of $344,000 for the quarter and a net loss of $596,000 for the six months ended June 30, 2024.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2024/23587305.html</guid>
   <pubDate>Mon, 12 Aug 2024 17:16:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for Second Quarter 2024</title>
   <link>http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2024/23587305.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Reports 9% Increase in Revenues; GLP-1 Medications Contribute to Growth

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and six months ended June 30, 2024. The Company reported net sales for the second quarter of 2024 of $5.8 million, a 9% increase over the same period in 2023, resulting from strong growth in partner services and B2C prescription revenue. The Company reported a net loss of $344,000 for the quarter and a net loss of $596,000 for the six months ended June 30, 2024.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2024/23587305.html</guid>
   <pubDate>Mon, 12 Aug 2024 17:16:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com, Inc. (HEWA) Reports Q1 Loss of $0.01</title>
   <link>http://www.streetinsider.com/Earnings/HealthWarehouse.com%2C+Inc.+%28HEWA%29+Reports+Q1+Loss+of+%240.01/23212610.html</link>
   <description>&lt;p&gt;HealthWarehouse.com, Inc. (OTC: HEWA) reported Q1 EPS of ($0.01). Revenue for the quarter came in at $5.12 million.&lt;/p&gt;&lt;p&gt;For earnings history and earnings-related data on HealthWarehouse.com, Inc. (HEWA) &lt;a href=&quot;http://www.streetinsider.com/ec_earnings.php?q=HEWA&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Earnings/HealthWarehouse.com%2C+Inc.+%28HEWA%29+Reports+Q1+Loss+of+%240.01/23212610.html</guid>
   <pubDate>Mon, 13 May 2024 07:56:53 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for First Quarter 2024</title>
   <link>http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2024/23212605.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Reports Growth in Direct-to-Consumer Prescription Sales and Positive EBITDA for the Quarter

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2023, totaled $5.1 million, a 3% decrease from the quarter ended March 31, 2023, resulting from a decline in over-the-counter sales. The Company reported a net loss of $252,412 and EBITDA of $89,723 for the quarter.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on healthcare e-commerce, sells and delivers prescription and over-the-counter medications to all 50 states as an Approved Digital Pharmacy through the National Association of Boards</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2024/23212605.html</guid>
   <pubDate>Mon, 13 May 2024 07:55:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for First Quarter 2024</title>
   <link>http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2024/23212605.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Reports Growth in Direct-to-Consumer Prescription Sales and Positive EBITDA for the Quarter

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2023, totaled $5.1 million, a 3% decrease from the quarter ended March 31, 2023, resulting from a decline in over-the-counter sales. The Company reported a net loss of $252,412 and EBITDA of $89,723 for the quarter.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on healthcare e-commerce, sells and delivers prescription and over-the-counter medications to all 50 states as an Approved Digital Pharmacy through the National Association of Boards</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2024/23212605.html</guid>
   <pubDate>Mon, 13 May 2024 07:55:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for First Quarter 2024</title>
   <link>http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2024/23212605.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Reports Growth in Direct-to-Consumer Prescription Sales and Positive EBITDA for the Quarter

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2023, totaled $5.1 million, a 3% decrease from the quarter ended March 31, 2023, resulting from a decline in over-the-counter sales. The Company reported a net loss of $252,412 and EBITDA of $89,723 for the quarter.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on healthcare e-commerce, sells and delivers prescription and over-the-counter medications to all 50 states as an Approved Digital Pharmacy through the National Association of Boards</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2024/23212605.html</guid>
   <pubDate>Mon, 13 May 2024 07:55:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for First Quarter 2024</title>
   <link>http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2024/23212605.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Reports Growth in Direct-to-Consumer Prescription Sales and Positive EBITDA for the Quarter

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2023, totaled $5.1 million, a 3% decrease from the quarter ended March 31, 2023, resulting from a decline in over-the-counter sales. The Company reported a net loss of $252,412 and EBITDA of $89,723 for the quarter.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on healthcare e-commerce, sells and delivers prescription and over-the-counter medications to all 50 states as an Approved Digital Pharmacy through the National Association of Boards</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2024/23212605.html</guid>
   <pubDate>Mon, 13 May 2024 07:55:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for First Quarter 2024</title>
   <link>http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+First+Quarter+2024/23212605.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Reports Growth in Direct-to-Consumer Prescription Sales and Positive EBITDA for the Quarter

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2023, totaled $5.1 million, a 3% decrease from the quarter ended March 31, 2023, resulting from a decline in over-the-counter sales. The Company reported a net loss of $252,412 and EBITDA of $89,723 for the quarter.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on healthcare e-commerce, sells and delivers prescription and over-the-counter medications to all 50 states as an Approved Digital Pharmacy through the National Association of Boards</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+First+Quarter+2024/23212605.html</guid>
   <pubDate>Mon, 13 May 2024 07:55:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for First Quarter 2024</title>
   <link>http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+First+Quarter+2024/23212605.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Reports Growth in Direct-to-Consumer Prescription Sales and Positive EBITDA for the Quarter

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2023, totaled $5.1 million, a 3% decrease from the quarter ended March 31, 2023, resulting from a decline in over-the-counter sales. The Company reported a net loss of $252,412 and EBITDA of $89,723 for the quarter.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on healthcare e-commerce, sells and delivers prescription and over-the-counter medications to all 50 states as an Approved Digital Pharmacy through the National Association of Boards</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+First+Quarter+2024/23212605.html</guid>
   <pubDate>Mon, 13 May 2024 07:55:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
  <item>
   <title>HealthWarehouse.com Reports Results for First Quarter 2024</title>
   <link>http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+First+Quarter+2024/23212605.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Reports Growth in Direct-to-Consumer Prescription Sales and Positive EBITDA for the Quarter

&lt;/p&gt;
&lt;p&gt;    CINCINNATI--(BUSINESS WIRE)--
HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2023, totaled $5.1 million, a 3% decrease from the quarter ended March 31, 2023, resulting from a decline in over-the-counter sales. The Company reported a net loss of $252,412 and EBITDA of $89,723 for the quarter.

&lt;/p&gt;&lt;p&gt;
HealthWarehouse.com, a technology company with a focus on healthcare e-commerce, sells and delivers prescription and over-the-counter medications to all 50 states as an Approved Digital Pharmacy through the National Association of Boards</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+First+Quarter+2024/23212605.html</guid>
   <pubDate>Mon, 13 May 2024 07:55:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.40071301</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEWA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064849</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16619048</category>
   	  </item>
 </channel>
</rss>
